Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Endonovo Therapeutics (ENDV) Preferred Shares (2018 - 2023)

Endonovo Therapeutics has reported Preferred Shares over the past 6 years, most recently at $1.0 for Q3 2023.

  • Quarterly results put Preferred Shares at $1.0 for Q3 2023, changed 0.0% from a year ago — trailing twelve months through Sep 2023 was $1.0 (changed 0.0% YoY), and the annual figure for FY2022 was $1.0, down 96.0%.
  • Preferred Shares for Q3 2023 was $1.0 at Endonovo Therapeutics, down from $25.0 in the prior quarter.
  • Over the last five years, Preferred Shares for ENDV hit a ceiling of $25.0 in Q1 2019 and a floor of $1.0 in Q2 2021.
  • Median Preferred Shares over the past 5 years was $25.0 (2019), compared with a mean of $17.42.
  • Biggest five-year swings in Preferred Shares: tumbled 96.0% in 2021 and later soared 2400.0% in 2023.
  • Endonovo Therapeutics' Preferred Shares stood at $25.0 in 2019, then changed by 0.0% to $25.0 in 2020, then changed by 0.0% to $25.0 in 2021, then tumbled by 96.0% to $1.0 in 2022, then changed by 0.0% to $1.0 in 2023.
  • The last three reported values for Preferred Shares were $1.0 (Q3 2023), $25.0 (Q2 2023), and $1.0 (Q1 2023) per Business Quant data.